Tebipenem
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Tebipenem
Description:
Tebipenem is an orally available carbapenem antibiotic, shows broad-spectrum activity against Gram-positive and -negative bacteria, except for Pseudomonas aeruginosa.Product Name Alternative:
LJC 11036UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
Antibiotic; BacterialType:
Reference compoundRelated Pathways:
Anti-infectionApplications:
COVID-19-immunoregulationField of Research:
InfectionAssay Protocol:
https://www.medchemexpress.com/Tebipenem.htmlPurity:
99.69Solubility:
DMSO : 33.33 mg/mL (ultrasonic) |H2O : 5.83 mg/mL (ultrasonic; warming; heat to 60°C)Smiles:
O=C (C (N1C2=O) =C (SC3CN (C4=NCCS4) C3) [C@H] (C) [C@]1 ([H]) [C@@]2 ([H]) [C@H] (O) C) OMolecular Formula:
C16H21N3O4S2Molecular Weight:
383.49Precautions:
H302, H315, H319, H335References & Citations:
[1]Hazra S, et al. Tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the β-lactamase from Mycobacterium tuberculosis. Biochemistry. 2014 Jun 10;53 (22) :3671-8|[2]Seenama C, et al. In vitro activity of tebipenem against Burkholderia pseudomallei. Int J Antimicrob Agents. 2013 Oct;42 (4) :375.|[3]Li H, et al. In vitro antibacterial activities of two novel oral antibiotics, tebipenem and cefditoren, and other comparators against community-acquired respiratory tract infection-associated bacterial pathogens: A multicentre study in China. Int J Antimicrob Agents. 2014 Jan;43 (1) :92-3.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Reference compound1Clinical Information:
Phase 3Isoform:
β-lactamCAS Number:
161715-21-5
